Current position:Home >Product >
2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, compd. with N-cyclohexylcyclohexanamine (1:1)
2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, compd. with N-cyclohexylcyclohexanamine (1:1)(1137606-74-6)
- Name: 2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, compd. with N-cyclohexylcyclohexanamine (1:1)
- Synonyms:2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, coMpd. with N-cyclohexylcyclohexanaMine (1:1)
- Molecular Formula:C12H23N.C5H2FN3O
- Molecular Weight:320.41
- CAS Registry Number:1137606-74-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 519188-42-2/Propanoic acid, 3-(2-benzo[b]thien-5-ylethoxy)-
- 519188-55-7/1-Propanone, 3-(2-benzo[b]thien-5-ylethoxy)-1-(3-hydroxy-1-azetidinyl)-
- 530141-72-1/Benzenepropanoic acid, 5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2,3-dihydro-3-oxo-1,2-benzisoxazol-6-yl)methoxy]-
- 753015-42-8/Pyridine, 3-[(1E)-2-(3R)-3-pyrrolidinylethenyl]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-
- 871484-32-1/Benzenebutanamide, 4-[[3-[(4-deoxy-4-fluoro-β-D-glucopyranosyl)oxy]-5-(1-methylethyl)-1H-pyrazol-4-yl]methyl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-
- 710281-33-7/Benzoic acid, 2-[[[(1R,3S)-3-[[2-(3-methoxyphenyl)-5-methyl-4-oxazolyl]methoxy]cyclohexyl]oxy]methyl]-6-methyl-
- 519187-97-4/3-Azetidinol, 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-, (2Z)-2-butenedioate (1:1)
- 165172-60-1/Thymidine, 2',3'-didehydro-3'-deoxy-, compd. with 1-methyl-2-pyrrolidinone (1:1) (9CI)
- 220099-91-2/Spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine], (2'R)-
- 220100-81-2/Spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine], (2'R)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1) (9CI)
- 163680-80-6/7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 10-[1-(acetylamino)cyclopropyl]-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (S)- (9CI)
- 690270-65-6/Cytidine, 4'-C-azido-, 2',3',5'-tris(2-methylpropanoate), hydrochloride (1:1)
- 812647-80-6/Uridine, 4'-C-azido-, 2',3'-dibenzoate 5'-(3-chlorobenzoate) (9CI)
- 866920-24-3/1,2,4-Oxadiazol-5(2H)-one, 3-[2-chloro-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methoxy]phenyl]-
- 127660-04-2/4-Thiazoleacetic acid, 2-amino-α-(hydroxyimino)-, monosodium salt, (αZ)- (9CI)
- 1137606-74-6/2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, compd. with N-cyclohexylcyclohexanamine (1:1)
- 259793-88-9/6-bromo-3-hydroxypyrazine-2-carboxamide
- 942436-93-3/3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-
- 942437-37-8/3-Cinnolinecarboxamide, 4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propyl-
- 912445-36-4/1H-Benzimidazole-7-carboxamide, 2-[(2S)-2-methyl-2-pyrrolidinyl]-, hydrochloride (1:2)
- 1000164-36-2/Alanine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-glutaminyl-L-alanyl-L-alanyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-1-[(1,1-dimethylethoxy)carbonyl]-L-tryptophyl-L-leucyl-L-valyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-2-methyl-, 5-(1,1-dimethylethyl) ester
- 540737-29-9/Tofacitinib citrate
- 475578-12-2/1,3-Bis(2-methylphenyl)-1H-imidazolium chloride
- 475578-18-8/4,5-Dihydro-1,3-bis(2-methylphenyl)-1H-imidazolium chloride
- 451487-18-6/4H-Cyclopentapyrimidin-4-one, 2-[[(4-fluorophenyl)methyl]thio]-1,5,6,7-tetrahydro- (9CI)
- 868210-14-4/Butanoic acid, 4-[4-[[(2S,4R)-4-[acetyl(4-chlorophenyl)amino]-3,4-dihydro-2-methyl-1(2H)-quinolinyl]carbonyl]phenoxy]-2,2-dimethyl-
- 356058-42-9/1H-Cyclopentapyrimidine-1-acetic acid, 2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-
- 1137917-12-4/Benzoic acid, 3-[[6-(ethylsulfonyl)-3-pyridinyl]oxy]-5-[(1S)-2-hydroxy-1-methylethoxy]-, compd. with 1,4-diazabicyclo[2.2.2]octane (2:1)
- 586414-48-4/Benzamide, 3-[3-bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1(2H)-pyridinyl]-N,4-dimethyl-, (-)-
- 941685-39-8/1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-